Quratis Inc. (KOSDAQ:348080)
487.00
-9.00 (-1.81%)
At close: Jun 5, 2026
Quratis Revenue
Quratis had revenue of 9.47M KRW in the quarter ending March 31, 2026, a decrease of -99.22%. This brings the company's revenue in the last twelve months to 1.26B, down -17.15% year-over-year. In the year 2025, Quratis had annual revenue of 2.46B with 557.29% growth.
Revenue (ttm)
1.26B
Revenue Growth
-17.15%
P/S Ratio
37.99
Revenue / Employee
n/a
Employees
n/a
Market Cap
47.71B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.46B | 2.08B | 557.29% |
| Dec 31, 2024 | 373.80M | -656.26M | -63.71% |
| Dec 31, 2023 | 1.03B | -6.49B | -86.31% |
| Dec 31, 2022 | 7.52B | 5.94B | 373.65% |
| Dec 31, 2021 | 1.59B | 1.48B | 1,344.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Psomagen | 60.70B |
| J2KBIO | 36.82B |
| PanGen Biotech | 13.71B |
| ADBiotech | 12.51B |
| HLB Pep | 5.52B |
| EyeGene | 4.02B |
| Aptamer Sciences | 1.08B |
| Progen | 450.00M |